Global Therapeutic Protein Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Therapeutic Protein Drug market size was valued at USD 221660 million in 2022 and is forecast to a readjusted size of USD 420270 million by 2029 with a CAGR of 9.6% during review period.
Protein therapy is a form of treatment that involves sending in well-structured proteins to a precise target location to repair or replace damaged ones. This is one of the most widely used treatment methods due to its accuracy and lack of negative side effects.
The Protein-based Therapeutics Market is driven by the increasing demand for innovative biopharmaceuticals that utilize proteins as therapeutic agents to treat a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. Protein-based therapies, such as monoclonal antibodies and recombinant proteins, offer highly targeted and precise treatment options. As scientific advancements and personalized medicine gain prominence, the demand for protein-based therapeutics continues to grow. Innovations in protein engineering, drug development, and manufacturing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, high production costs, and regulatory standards while ensuring accessibility and affordability for patients. Overcoming research and development challenges, optimizing drug manufacturing, and adapting to evolving healthcare regulations are ongoing hurdles. Additionally, the market faces competition from small molecules and gene-based therapies, necessitating continuous innovation to unlock the full therapeutic potential of protein-based drugs. Striking a balance between providing safe, effective, and accessible protein-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Protein-based Therapeutics Market.
The Global Info Research report includes an overview of the development of the Therapeutic Protein Drug industry chain, the market status of Immune Diseases (Antibody-based Drugs, Fc Fusion Proteins), Cancer (Antibody-based Drugs, Fc Fusion Proteins), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Therapeutic Protein Drug.
Regionally, the report analyzes the Therapeutic Protein Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Therapeutic Protein Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Therapeutic Protein Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Therapeutic Protein Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antibody-based Drugs, Fc Fusion Proteins).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Therapeutic Protein Drug market.
Regional Analysis: The report involves examining the Therapeutic Protein Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Therapeutic Protein Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Therapeutic Protein Drug:
Company Analysis: Report covers individual Therapeutic Protein Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Therapeutic Protein Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immune Diseases, Cancer).
Technology Analysis: Report covers specific technologies relevant to Therapeutic Protein Drug. It assesses the current state, advancements, and potential future developments in Therapeutic Protein Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Therapeutic Protein Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Therapeutic Protein Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Therapeutic Protein Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Protein Drug, with revenue, gross margin and global market share of Therapeutic Protein Drug from 2018 to 2023.
Chapter 3, the Therapeutic Protein Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Therapeutic Protein Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Protein Drug.
Chapter 13, to describe Therapeutic Protein Drug research findings and conclusion.
Protein therapy is a form of treatment that involves sending in well-structured proteins to a precise target location to repair or replace damaged ones. This is one of the most widely used treatment methods due to its accuracy and lack of negative side effects.
The Protein-based Therapeutics Market is driven by the increasing demand for innovative biopharmaceuticals that utilize proteins as therapeutic agents to treat a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. Protein-based therapies, such as monoclonal antibodies and recombinant proteins, offer highly targeted and precise treatment options. As scientific advancements and personalized medicine gain prominence, the demand for protein-based therapeutics continues to grow. Innovations in protein engineering, drug development, and manufacturing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, high production costs, and regulatory standards while ensuring accessibility and affordability for patients. Overcoming research and development challenges, optimizing drug manufacturing, and adapting to evolving healthcare regulations are ongoing hurdles. Additionally, the market faces competition from small molecules and gene-based therapies, necessitating continuous innovation to unlock the full therapeutic potential of protein-based drugs. Striking a balance between providing safe, effective, and accessible protein-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Protein-based Therapeutics Market.
The Global Info Research report includes an overview of the development of the Therapeutic Protein Drug industry chain, the market status of Immune Diseases (Antibody-based Drugs, Fc Fusion Proteins), Cancer (Antibody-based Drugs, Fc Fusion Proteins), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Therapeutic Protein Drug.
Regionally, the report analyzes the Therapeutic Protein Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Therapeutic Protein Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Therapeutic Protein Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Therapeutic Protein Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antibody-based Drugs, Fc Fusion Proteins).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Therapeutic Protein Drug market.
Regional Analysis: The report involves examining the Therapeutic Protein Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Therapeutic Protein Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Therapeutic Protein Drug:
Company Analysis: Report covers individual Therapeutic Protein Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Therapeutic Protein Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immune Diseases, Cancer).
Technology Analysis: Report covers specific technologies relevant to Therapeutic Protein Drug. It assesses the current state, advancements, and potential future developments in Therapeutic Protein Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Therapeutic Protein Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Therapeutic Protein Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Antibody-based Drugs
- Fc Fusion Proteins
- Anticoagulants
- Blood Factors
- Other
- Immune Diseases
- Cancer
- Other
- AbbVie
- Johnson & Johnson
- Novartis
- Gilead Sciences
- Roche
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Merck & Co
- Takeda
- Merck KGaA
- Seagen
- Eli Lilly
- Ono Pharmaceutical
- Pfizer
- Regeneron
- Innovent
- Hengrui Medicine
- Sanofi
- Sobi
- Kanghong Pharma
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Therapeutic Protein Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Protein Drug, with revenue, gross margin and global market share of Therapeutic Protein Drug from 2018 to 2023.
Chapter 3, the Therapeutic Protein Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Therapeutic Protein Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Protein Drug.
Chapter 13, to describe Therapeutic Protein Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Therapeutic Protein Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Therapeutic Protein Drug by Type
1.3.1 Overview: Global Therapeutic Protein Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Therapeutic Protein Drug Consumption Value Market Share by Type in 2022
1.3.3 Antibody-based Drugs
1.3.4 Fc Fusion Proteins
1.3.5 Anticoagulants
1.3.6 Blood Factors
1.3.7 Other
1.4 Global Therapeutic Protein Drug Market by Application
1.4.1 Overview: Global Therapeutic Protein Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immune Diseases
1.4.3 Cancer
1.4.4 Other
1.5 Global Therapeutic Protein Drug Market Size & Forecast
1.6 Global Therapeutic Protein Drug Market Size and Forecast by Region
1.6.1 Global Therapeutic Protein Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Therapeutic Protein Drug Market Size by Region, (2018-2029)
1.6.3 North America Therapeutic Protein Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Therapeutic Protein Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Therapeutic Protein Drug Market Size and Prospect (2018-2029)
1.6.6 South America Therapeutic Protein Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Therapeutic Protein Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Therapeutic Protein Drug Product and Solutions
2.1.4 AbbVie Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Therapeutic Protein Drug Product and Solutions
2.2.4 Johnson & Johnson Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Therapeutic Protein Drug Product and Solutions
2.3.4 Novartis Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business
2.4.3 Gilead Sciences Therapeutic Protein Drug Product and Solutions
2.4.4 Gilead Sciences Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Gilead Sciences Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Therapeutic Protein Drug Product and Solutions
2.5.4 Roche Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Roche Recent Developments and Future Plans
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Therapeutic Protein Drug Product and Solutions
2.6.4 Bristol-Myers Squibb Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business
2.7.3 Amgen Therapeutic Protein Drug Product and Solutions
2.7.4 Amgen Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Amgen Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Therapeutic Protein Drug Product and Solutions
2.8.4 AstraZeneca Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Merck & Co
2.9.1 Merck & Co Details
2.9.2 Merck & Co Major Business
2.9.3 Merck & Co Therapeutic Protein Drug Product and Solutions
2.9.4 Merck & Co Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck & Co Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Therapeutic Protein Drug Product and Solutions
2.10.4 Takeda Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Takeda Recent Developments and Future Plans
2.11 Merck KGaA
2.11.1 Merck KGaA Details
2.11.2 Merck KGaA Major Business
2.11.3 Merck KGaA Therapeutic Protein Drug Product and Solutions
2.11.4 Merck KGaA Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Merck KGaA Recent Developments and Future Plans
2.12 Seagen
2.12.1 Seagen Details
2.12.2 Seagen Major Business
2.12.3 Seagen Therapeutic Protein Drug Product and Solutions
2.12.4 Seagen Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Seagen Recent Developments and Future Plans
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Therapeutic Protein Drug Product and Solutions
2.13.4 Eli Lilly Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Eli Lilly Recent Developments and Future Plans
2.14 Ono Pharmaceutical
2.14.1 Ono Pharmaceutical Details
2.14.2 Ono Pharmaceutical Major Business
2.14.3 Ono Pharmaceutical Therapeutic Protein Drug Product and Solutions
2.14.4 Ono Pharmaceutical Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Ono Pharmaceutical Recent Developments and Future Plans
2.15 Pfizer
2.15.1 Pfizer Details
2.15.2 Pfizer Major Business
2.15.3 Pfizer Therapeutic Protein Drug Product and Solutions
2.15.4 Pfizer Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Pfizer Recent Developments and Future Plans
2.16 Regeneron
2.16.1 Regeneron Details
2.16.2 Regeneron Major Business
2.16.3 Regeneron Therapeutic Protein Drug Product and Solutions
2.16.4 Regeneron Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Regeneron Recent Developments and Future Plans
2.17 Innovent
2.17.1 Innovent Details
2.17.2 Innovent Major Business
2.17.3 Innovent Therapeutic Protein Drug Product and Solutions
2.17.4 Innovent Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Innovent Recent Developments and Future Plans
2.18 Hengrui Medicine
2.18.1 Hengrui Medicine Details
2.18.2 Hengrui Medicine Major Business
2.18.3 Hengrui Medicine Therapeutic Protein Drug Product and Solutions
2.18.4 Hengrui Medicine Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Hengrui Medicine Recent Developments and Future Plans
2.19 Sanofi
2.19.1 Sanofi Details
2.19.2 Sanofi Major Business
2.19.3 Sanofi Therapeutic Protein Drug Product and Solutions
2.19.4 Sanofi Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Sanofi Recent Developments and Future Plans
2.20 Sobi
2.20.1 Sobi Details
2.20.2 Sobi Major Business
2.20.3 Sobi Therapeutic Protein Drug Product and Solutions
2.20.4 Sobi Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Sobi Recent Developments and Future Plans
2.21 Kanghong Pharma
2.21.1 Kanghong Pharma Details
2.21.2 Kanghong Pharma Major Business
2.21.3 Kanghong Pharma Therapeutic Protein Drug Product and Solutions
2.21.4 Kanghong Pharma Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Kanghong Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Therapeutic Protein Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Therapeutic Protein Drug by Company Revenue
3.2.2 Top 3 Therapeutic Protein Drug Players Market Share in 2022
3.2.3 Top 6 Therapeutic Protein Drug Players Market Share in 2022
3.3 Therapeutic Protein Drug Market: Overall Company Footprint Analysis
3.3.1 Therapeutic Protein Drug Market: Region Footprint
3.3.2 Therapeutic Protein Drug Market: Company Product Type Footprint
3.3.3 Therapeutic Protein Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Therapeutic Protein Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Therapeutic Protein Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Therapeutic Protein Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Therapeutic Protein Drug Consumption Value by Type (2018-2029)
6.2 North America Therapeutic Protein Drug Consumption Value by Application (2018-2029)
6.3 North America Therapeutic Protein Drug Market Size by Country
6.3.1 North America Therapeutic Protein Drug Consumption Value by Country (2018-2029)
6.3.2 United States Therapeutic Protein Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Therapeutic Protein Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Therapeutic Protein Drug Consumption Value by Type (2018-2029)
7.2 Europe Therapeutic Protein Drug Consumption Value by Application (2018-2029)
7.3 Europe Therapeutic Protein Drug Market Size by Country
7.3.1 Europe Therapeutic Protein Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7.3.3 France Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Therapeutic Protein Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Therapeutic Protein Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Therapeutic Protein Drug Market Size by Region
8.3.1 Asia-Pacific Therapeutic Protein Drug Consumption Value by Region (2018-2029)
8.3.2 China Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.5 India Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Therapeutic Protein Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Therapeutic Protein Drug Consumption Value by Type (2018-2029)
9.2 South America Therapeutic Protein Drug Consumption Value by Application (2018-2029)
9.3 South America Therapeutic Protein Drug Market Size by Country
9.3.1 South America Therapeutic Protein Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Therapeutic Protein Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Therapeutic Protein Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Therapeutic Protein Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Therapeutic Protein Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Therapeutic Protein Drug Market Size by Country
10.3.1 Middle East & Africa Therapeutic Protein Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Therapeutic Protein Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Therapeutic Protein Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Therapeutic Protein Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Therapeutic Protein Drug Market Drivers
11.2 Therapeutic Protein Drug Market Restraints
11.3 Therapeutic Protein Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Therapeutic Protein Drug Industry Chain
12.2 Therapeutic Protein Drug Upstream Analysis
12.3 Therapeutic Protein Drug Midstream Analysis
12.4 Therapeutic Protein Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Therapeutic Protein Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Therapeutic Protein Drug by Type
1.3.1 Overview: Global Therapeutic Protein Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Therapeutic Protein Drug Consumption Value Market Share by Type in 2022
1.3.3 Antibody-based Drugs
1.3.4 Fc Fusion Proteins
1.3.5 Anticoagulants
1.3.6 Blood Factors
1.3.7 Other
1.4 Global Therapeutic Protein Drug Market by Application
1.4.1 Overview: Global Therapeutic Protein Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immune Diseases
1.4.3 Cancer
1.4.4 Other
1.5 Global Therapeutic Protein Drug Market Size & Forecast
1.6 Global Therapeutic Protein Drug Market Size and Forecast by Region
1.6.1 Global Therapeutic Protein Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Therapeutic Protein Drug Market Size by Region, (2018-2029)
1.6.3 North America Therapeutic Protein Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Therapeutic Protein Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Therapeutic Protein Drug Market Size and Prospect (2018-2029)
1.6.6 South America Therapeutic Protein Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Therapeutic Protein Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Therapeutic Protein Drug Product and Solutions
2.1.4 AbbVie Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Therapeutic Protein Drug Product and Solutions
2.2.4 Johnson & Johnson Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Therapeutic Protein Drug Product and Solutions
2.3.4 Novartis Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business
2.4.3 Gilead Sciences Therapeutic Protein Drug Product and Solutions
2.4.4 Gilead Sciences Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Gilead Sciences Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Therapeutic Protein Drug Product and Solutions
2.5.4 Roche Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Roche Recent Developments and Future Plans
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Therapeutic Protein Drug Product and Solutions
2.6.4 Bristol-Myers Squibb Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business
2.7.3 Amgen Therapeutic Protein Drug Product and Solutions
2.7.4 Amgen Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Amgen Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Therapeutic Protein Drug Product and Solutions
2.8.4 AstraZeneca Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Merck & Co
2.9.1 Merck & Co Details
2.9.2 Merck & Co Major Business
2.9.3 Merck & Co Therapeutic Protein Drug Product and Solutions
2.9.4 Merck & Co Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck & Co Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Therapeutic Protein Drug Product and Solutions
2.10.4 Takeda Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Takeda Recent Developments and Future Plans
2.11 Merck KGaA
2.11.1 Merck KGaA Details
2.11.2 Merck KGaA Major Business
2.11.3 Merck KGaA Therapeutic Protein Drug Product and Solutions
2.11.4 Merck KGaA Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Merck KGaA Recent Developments and Future Plans
2.12 Seagen
2.12.1 Seagen Details
2.12.2 Seagen Major Business
2.12.3 Seagen Therapeutic Protein Drug Product and Solutions
2.12.4 Seagen Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Seagen Recent Developments and Future Plans
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Therapeutic Protein Drug Product and Solutions
2.13.4 Eli Lilly Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Eli Lilly Recent Developments and Future Plans
2.14 Ono Pharmaceutical
2.14.1 Ono Pharmaceutical Details
2.14.2 Ono Pharmaceutical Major Business
2.14.3 Ono Pharmaceutical Therapeutic Protein Drug Product and Solutions
2.14.4 Ono Pharmaceutical Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Ono Pharmaceutical Recent Developments and Future Plans
2.15 Pfizer
2.15.1 Pfizer Details
2.15.2 Pfizer Major Business
2.15.3 Pfizer Therapeutic Protein Drug Product and Solutions
2.15.4 Pfizer Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Pfizer Recent Developments and Future Plans
2.16 Regeneron
2.16.1 Regeneron Details
2.16.2 Regeneron Major Business
2.16.3 Regeneron Therapeutic Protein Drug Product and Solutions
2.16.4 Regeneron Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Regeneron Recent Developments and Future Plans
2.17 Innovent
2.17.1 Innovent Details
2.17.2 Innovent Major Business
2.17.3 Innovent Therapeutic Protein Drug Product and Solutions
2.17.4 Innovent Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Innovent Recent Developments and Future Plans
2.18 Hengrui Medicine
2.18.1 Hengrui Medicine Details
2.18.2 Hengrui Medicine Major Business
2.18.3 Hengrui Medicine Therapeutic Protein Drug Product and Solutions
2.18.4 Hengrui Medicine Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Hengrui Medicine Recent Developments and Future Plans
2.19 Sanofi
2.19.1 Sanofi Details
2.19.2 Sanofi Major Business
2.19.3 Sanofi Therapeutic Protein Drug Product and Solutions
2.19.4 Sanofi Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Sanofi Recent Developments and Future Plans
2.20 Sobi
2.20.1 Sobi Details
2.20.2 Sobi Major Business
2.20.3 Sobi Therapeutic Protein Drug Product and Solutions
2.20.4 Sobi Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Sobi Recent Developments and Future Plans
2.21 Kanghong Pharma
2.21.1 Kanghong Pharma Details
2.21.2 Kanghong Pharma Major Business
2.21.3 Kanghong Pharma Therapeutic Protein Drug Product and Solutions
2.21.4 Kanghong Pharma Therapeutic Protein Drug Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Kanghong Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Therapeutic Protein Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Therapeutic Protein Drug by Company Revenue
3.2.2 Top 3 Therapeutic Protein Drug Players Market Share in 2022
3.2.3 Top 6 Therapeutic Protein Drug Players Market Share in 2022
3.3 Therapeutic Protein Drug Market: Overall Company Footprint Analysis
3.3.1 Therapeutic Protein Drug Market: Region Footprint
3.3.2 Therapeutic Protein Drug Market: Company Product Type Footprint
3.3.3 Therapeutic Protein Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Therapeutic Protein Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Therapeutic Protein Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Therapeutic Protein Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Therapeutic Protein Drug Consumption Value by Type (2018-2029)
6.2 North America Therapeutic Protein Drug Consumption Value by Application (2018-2029)
6.3 North America Therapeutic Protein Drug Market Size by Country
6.3.1 North America Therapeutic Protein Drug Consumption Value by Country (2018-2029)
6.3.2 United States Therapeutic Protein Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Therapeutic Protein Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Therapeutic Protein Drug Consumption Value by Type (2018-2029)
7.2 Europe Therapeutic Protein Drug Consumption Value by Application (2018-2029)
7.3 Europe Therapeutic Protein Drug Market Size by Country
7.3.1 Europe Therapeutic Protein Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7.3.3 France Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Therapeutic Protein Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Therapeutic Protein Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Therapeutic Protein Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Therapeutic Protein Drug Market Size by Region
8.3.1 Asia-Pacific Therapeutic Protein Drug Consumption Value by Region (2018-2029)
8.3.2 China Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.5 India Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Therapeutic Protein Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Therapeutic Protein Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Therapeutic Protein Drug Consumption Value by Type (2018-2029)
9.2 South America Therapeutic Protein Drug Consumption Value by Application (2018-2029)
9.3 South America Therapeutic Protein Drug Market Size by Country
9.3.1 South America Therapeutic Protein Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Therapeutic Protein Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Therapeutic Protein Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Therapeutic Protein Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Therapeutic Protein Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Therapeutic Protein Drug Market Size by Country
10.3.1 Middle East & Africa Therapeutic Protein Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Therapeutic Protein Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Therapeutic Protein Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Therapeutic Protein Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Therapeutic Protein Drug Market Drivers
11.2 Therapeutic Protein Drug Market Restraints
11.3 Therapeutic Protein Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Therapeutic Protein Drug Industry Chain
12.2 Therapeutic Protein Drug Upstream Analysis
12.3 Therapeutic Protein Drug Midstream Analysis
12.4 Therapeutic Protein Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Therapeutic Protein Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Therapeutic Protein Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Therapeutic Protein Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Therapeutic Protein Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Therapeutic Protein Drug Product and Solutions
Table 8. AbbVie Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Therapeutic Protein Drug Product and Solutions
Table 13. Johnson & Johnson Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Therapeutic Protein Drug Product and Solutions
Table 18. Novartis Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 21. Gilead Sciences Major Business
Table 22. Gilead Sciences Therapeutic Protein Drug Product and Solutions
Table 23. Gilead Sciences Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Gilead Sciences Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Therapeutic Protein Drug Product and Solutions
Table 28. Roche Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Roche Recent Developments and Future Plans
Table 30. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 31. Bristol-Myers Squibb Major Business
Table 32. Bristol-Myers Squibb Therapeutic Protein Drug Product and Solutions
Table 33. Bristol-Myers Squibb Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bristol-Myers Squibb Recent Developments and Future Plans
Table 35. Amgen Company Information, Head Office, and Major Competitors
Table 36. Amgen Major Business
Table 37. Amgen Therapeutic Protein Drug Product and Solutions
Table 38. Amgen Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Amgen Recent Developments and Future Plans
Table 40. AstraZeneca Company Information, Head Office, and Major Competitors
Table 41. AstraZeneca Major Business
Table 42. AstraZeneca Therapeutic Protein Drug Product and Solutions
Table 43. AstraZeneca Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. AstraZeneca Recent Developments and Future Plans
Table 45. Merck & Co Company Information, Head Office, and Major Competitors
Table 46. Merck & Co Major Business
Table 47. Merck & Co Therapeutic Protein Drug Product and Solutions
Table 48. Merck & Co Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck & Co Recent Developments and Future Plans
Table 50. Takeda Company Information, Head Office, and Major Competitors
Table 51. Takeda Major Business
Table 52. Takeda Therapeutic Protein Drug Product and Solutions
Table 53. Takeda Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Takeda Recent Developments and Future Plans
Table 55. Merck KGaA Company Information, Head Office, and Major Competitors
Table 56. Merck KGaA Major Business
Table 57. Merck KGaA Therapeutic Protein Drug Product and Solutions
Table 58. Merck KGaA Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Merck KGaA Recent Developments and Future Plans
Table 60. Seagen Company Information, Head Office, and Major Competitors
Table 61. Seagen Major Business
Table 62. Seagen Therapeutic Protein Drug Product and Solutions
Table 63. Seagen Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Seagen Recent Developments and Future Plans
Table 65. Eli Lilly Company Information, Head Office, and Major Competitors
Table 66. Eli Lilly Major Business
Table 67. Eli Lilly Therapeutic Protein Drug Product and Solutions
Table 68. Eli Lilly Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Eli Lilly Recent Developments and Future Plans
Table 70. Ono Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. Ono Pharmaceutical Major Business
Table 72. Ono Pharmaceutical Therapeutic Protein Drug Product and Solutions
Table 73. Ono Pharmaceutical Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Ono Pharmaceutical Recent Developments and Future Plans
Table 75. Pfizer Company Information, Head Office, and Major Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Therapeutic Protein Drug Product and Solutions
Table 78. Pfizer Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Pfizer Recent Developments and Future Plans
Table 80. Regeneron Company Information, Head Office, and Major Competitors
Table 81. Regeneron Major Business
Table 82. Regeneron Therapeutic Protein Drug Product and Solutions
Table 83. Regeneron Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Regeneron Recent Developments and Future Plans
Table 85. Innovent Company Information, Head Office, and Major Competitors
Table 86. Innovent Major Business
Table 87. Innovent Therapeutic Protein Drug Product and Solutions
Table 88. Innovent Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Innovent Recent Developments and Future Plans
Table 90. Hengrui Medicine Company Information, Head Office, and Major Competitors
Table 91. Hengrui Medicine Major Business
Table 92. Hengrui Medicine Therapeutic Protein Drug Product and Solutions
Table 93. Hengrui Medicine Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Hengrui Medicine Recent Developments and Future Plans
Table 95. Sanofi Company Information, Head Office, and Major Competitors
Table 96. Sanofi Major Business
Table 97. Sanofi Therapeutic Protein Drug Product and Solutions
Table 98. Sanofi Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Sanofi Recent Developments and Future Plans
Table 100. Sobi Company Information, Head Office, and Major Competitors
Table 101. Sobi Major Business
Table 102. Sobi Therapeutic Protein Drug Product and Solutions
Table 103. Sobi Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Sobi Recent Developments and Future Plans
Table 105. Kanghong Pharma Company Information, Head Office, and Major Competitors
Table 106. Kanghong Pharma Major Business
Table 107. Kanghong Pharma Therapeutic Protein Drug Product and Solutions
Table 108. Kanghong Pharma Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Kanghong Pharma Recent Developments and Future Plans
Table 110. Global Therapeutic Protein Drug Revenue (USD Million) by Players (2018-2023)
Table 111. Global Therapeutic Protein Drug Revenue Share by Players (2018-2023)
Table 112. Breakdown of Therapeutic Protein Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Therapeutic Protein Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Therapeutic Protein Drug Players
Table 115. Therapeutic Protein Drug Market: Company Product Type Footprint
Table 116. Therapeutic Protein Drug Market: Company Product Application Footprint
Table 117. Therapeutic Protein Drug New Market Entrants and Barriers to Market Entry
Table 118. Therapeutic Protein Drug Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Therapeutic Protein Drug Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Therapeutic Protein Drug Consumption Value Share by Type (2018-2023)
Table 121. Global Therapeutic Protein Drug Consumption Value Forecast by Type (2024-2029)
Table 122. Global Therapeutic Protein Drug Consumption Value by Application (2018-2023)
Table 123. Global Therapeutic Protein Drug Consumption Value Forecast by Application (2024-2029)
Table 124. North America Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Therapeutic Protein Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Therapeutic Protein Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Therapeutic Protein Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Therapeutic Protein Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Therapeutic Protein Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Therapeutic Protein Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Therapeutic Protein Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Therapeutic Protein Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Therapeutic Protein Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Therapeutic Protein Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Therapeutic Protein Drug Raw Material
Table 155. Key Suppliers of Therapeutic Protein Drug Raw Materials
LIST OF FIGURE
s
Figure 1. Therapeutic Protein Drug Picture
Figure 2. Global Therapeutic Protein Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Therapeutic Protein Drug Consumption Value Market Share by Type in 2022
Figure 4. Antibody-based Drugs
Figure 5. Fc Fusion Proteins
Figure 6. Anticoagulants
Figure 7. Blood Factors
Figure 8. Other
Figure 9. Global Therapeutic Protein Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Therapeutic Protein Drug Consumption Value Market Share by Application in 2022
Figure 11. Immune Diseases Picture
Figure 12. Cancer Picture
Figure 13. Other Picture
Figure 14. Global Therapeutic Protein Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Therapeutic Protein Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Therapeutic Protein Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Therapeutic Protein Drug Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Therapeutic Protein Drug Consumption Value Market Share by Region in 2022
Figure 19. North America Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Therapeutic Protein Drug Revenue Share by Players in 2022
Figure 25. Therapeutic Protein Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Therapeutic Protein Drug Market Share in 2022
Figure 27. Global Top 6 Players Therapeutic Protein Drug Market Share in 2022
Figure 28. Global Therapeutic Protein Drug Consumption Value Share by Type (2018-2023)
Figure 29. Global Therapeutic Protein Drug Market Share Forecast by Type (2024-2029)
Figure 30. Global Therapeutic Protein Drug Consumption Value Share by Application (2018-2023)
Figure 31. Global Therapeutic Protein Drug Market Share Forecast by Application (2024-2029)
Figure 32. North America Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Therapeutic Protein Drug Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Therapeutic Protein Drug Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. France Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Therapeutic Protein Drug Consumption Value Market Share by Region (2018-2029)
Figure 49. China Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. India Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Therapeutic Protein Drug Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Therapeutic Protein Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 66. Therapeutic Protein Drug Market Drivers
Figure 67. Therapeutic Protein Drug Market Restraints
Figure 68. Therapeutic Protein Drug Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Therapeutic Protein Drug in 2022
Figure 71. Manufacturing Process Analysis of Therapeutic Protein Drug
Figure 72. Therapeutic Protein Drug Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Table 1. Global Therapeutic Protein Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Therapeutic Protein Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Therapeutic Protein Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Therapeutic Protein Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Therapeutic Protein Drug Product and Solutions
Table 8. AbbVie Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Therapeutic Protein Drug Product and Solutions
Table 13. Johnson & Johnson Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Therapeutic Protein Drug Product and Solutions
Table 18. Novartis Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 21. Gilead Sciences Major Business
Table 22. Gilead Sciences Therapeutic Protein Drug Product and Solutions
Table 23. Gilead Sciences Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Gilead Sciences Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Therapeutic Protein Drug Product and Solutions
Table 28. Roche Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Roche Recent Developments and Future Plans
Table 30. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 31. Bristol-Myers Squibb Major Business
Table 32. Bristol-Myers Squibb Therapeutic Protein Drug Product and Solutions
Table 33. Bristol-Myers Squibb Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bristol-Myers Squibb Recent Developments and Future Plans
Table 35. Amgen Company Information, Head Office, and Major Competitors
Table 36. Amgen Major Business
Table 37. Amgen Therapeutic Protein Drug Product and Solutions
Table 38. Amgen Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Amgen Recent Developments and Future Plans
Table 40. AstraZeneca Company Information, Head Office, and Major Competitors
Table 41. AstraZeneca Major Business
Table 42. AstraZeneca Therapeutic Protein Drug Product and Solutions
Table 43. AstraZeneca Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. AstraZeneca Recent Developments and Future Plans
Table 45. Merck & Co Company Information, Head Office, and Major Competitors
Table 46. Merck & Co Major Business
Table 47. Merck & Co Therapeutic Protein Drug Product and Solutions
Table 48. Merck & Co Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck & Co Recent Developments and Future Plans
Table 50. Takeda Company Information, Head Office, and Major Competitors
Table 51. Takeda Major Business
Table 52. Takeda Therapeutic Protein Drug Product and Solutions
Table 53. Takeda Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Takeda Recent Developments and Future Plans
Table 55. Merck KGaA Company Information, Head Office, and Major Competitors
Table 56. Merck KGaA Major Business
Table 57. Merck KGaA Therapeutic Protein Drug Product and Solutions
Table 58. Merck KGaA Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Merck KGaA Recent Developments and Future Plans
Table 60. Seagen Company Information, Head Office, and Major Competitors
Table 61. Seagen Major Business
Table 62. Seagen Therapeutic Protein Drug Product and Solutions
Table 63. Seagen Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Seagen Recent Developments and Future Plans
Table 65. Eli Lilly Company Information, Head Office, and Major Competitors
Table 66. Eli Lilly Major Business
Table 67. Eli Lilly Therapeutic Protein Drug Product and Solutions
Table 68. Eli Lilly Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Eli Lilly Recent Developments and Future Plans
Table 70. Ono Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. Ono Pharmaceutical Major Business
Table 72. Ono Pharmaceutical Therapeutic Protein Drug Product and Solutions
Table 73. Ono Pharmaceutical Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Ono Pharmaceutical Recent Developments and Future Plans
Table 75. Pfizer Company Information, Head Office, and Major Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Therapeutic Protein Drug Product and Solutions
Table 78. Pfizer Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Pfizer Recent Developments and Future Plans
Table 80. Regeneron Company Information, Head Office, and Major Competitors
Table 81. Regeneron Major Business
Table 82. Regeneron Therapeutic Protein Drug Product and Solutions
Table 83. Regeneron Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Regeneron Recent Developments and Future Plans
Table 85. Innovent Company Information, Head Office, and Major Competitors
Table 86. Innovent Major Business
Table 87. Innovent Therapeutic Protein Drug Product and Solutions
Table 88. Innovent Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Innovent Recent Developments and Future Plans
Table 90. Hengrui Medicine Company Information, Head Office, and Major Competitors
Table 91. Hengrui Medicine Major Business
Table 92. Hengrui Medicine Therapeutic Protein Drug Product and Solutions
Table 93. Hengrui Medicine Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Hengrui Medicine Recent Developments and Future Plans
Table 95. Sanofi Company Information, Head Office, and Major Competitors
Table 96. Sanofi Major Business
Table 97. Sanofi Therapeutic Protein Drug Product and Solutions
Table 98. Sanofi Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Sanofi Recent Developments and Future Plans
Table 100. Sobi Company Information, Head Office, and Major Competitors
Table 101. Sobi Major Business
Table 102. Sobi Therapeutic Protein Drug Product and Solutions
Table 103. Sobi Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Sobi Recent Developments and Future Plans
Table 105. Kanghong Pharma Company Information, Head Office, and Major Competitors
Table 106. Kanghong Pharma Major Business
Table 107. Kanghong Pharma Therapeutic Protein Drug Product and Solutions
Table 108. Kanghong Pharma Therapeutic Protein Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Kanghong Pharma Recent Developments and Future Plans
Table 110. Global Therapeutic Protein Drug Revenue (USD Million) by Players (2018-2023)
Table 111. Global Therapeutic Protein Drug Revenue Share by Players (2018-2023)
Table 112. Breakdown of Therapeutic Protein Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Therapeutic Protein Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Therapeutic Protein Drug Players
Table 115. Therapeutic Protein Drug Market: Company Product Type Footprint
Table 116. Therapeutic Protein Drug Market: Company Product Application Footprint
Table 117. Therapeutic Protein Drug New Market Entrants and Barriers to Market Entry
Table 118. Therapeutic Protein Drug Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Therapeutic Protein Drug Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Therapeutic Protein Drug Consumption Value Share by Type (2018-2023)
Table 121. Global Therapeutic Protein Drug Consumption Value Forecast by Type (2024-2029)
Table 122. Global Therapeutic Protein Drug Consumption Value by Application (2018-2023)
Table 123. Global Therapeutic Protein Drug Consumption Value Forecast by Application (2024-2029)
Table 124. North America Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Therapeutic Protein Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Therapeutic Protein Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Therapeutic Protein Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Therapeutic Protein Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Therapeutic Protein Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Therapeutic Protein Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Therapeutic Protein Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Therapeutic Protein Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Therapeutic Protein Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Therapeutic Protein Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Therapeutic Protein Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Therapeutic Protein Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Therapeutic Protein Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Therapeutic Protein Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Therapeutic Protein Drug Raw Material
Table 155. Key Suppliers of Therapeutic Protein Drug Raw Materials
LIST OF FIGURE
s
Figure 1. Therapeutic Protein Drug Picture
Figure 2. Global Therapeutic Protein Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Therapeutic Protein Drug Consumption Value Market Share by Type in 2022
Figure 4. Antibody-based Drugs
Figure 5. Fc Fusion Proteins
Figure 6. Anticoagulants
Figure 7. Blood Factors
Figure 8. Other
Figure 9. Global Therapeutic Protein Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Therapeutic Protein Drug Consumption Value Market Share by Application in 2022
Figure 11. Immune Diseases Picture
Figure 12. Cancer Picture
Figure 13. Other Picture
Figure 14. Global Therapeutic Protein Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Therapeutic Protein Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Therapeutic Protein Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Therapeutic Protein Drug Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Therapeutic Protein Drug Consumption Value Market Share by Region in 2022
Figure 19. North America Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Therapeutic Protein Drug Revenue Share by Players in 2022
Figure 25. Therapeutic Protein Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Therapeutic Protein Drug Market Share in 2022
Figure 27. Global Top 6 Players Therapeutic Protein Drug Market Share in 2022
Figure 28. Global Therapeutic Protein Drug Consumption Value Share by Type (2018-2023)
Figure 29. Global Therapeutic Protein Drug Market Share Forecast by Type (2024-2029)
Figure 30. Global Therapeutic Protein Drug Consumption Value Share by Application (2018-2023)
Figure 31. Global Therapeutic Protein Drug Market Share Forecast by Application (2024-2029)
Figure 32. North America Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Therapeutic Protein Drug Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Therapeutic Protein Drug Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. France Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Therapeutic Protein Drug Consumption Value Market Share by Region (2018-2029)
Figure 49. China Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. India Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Therapeutic Protein Drug Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Therapeutic Protein Drug Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Therapeutic Protein Drug Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Therapeutic Protein Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Therapeutic Protein Drug Consumption Value (2018-2029) & (USD Million)
Figure 66. Therapeutic Protein Drug Market Drivers
Figure 67. Therapeutic Protein Drug Market Restraints
Figure 68. Therapeutic Protein Drug Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Therapeutic Protein Drug in 2022
Figure 71. Manufacturing Process Analysis of Therapeutic Protein Drug
Figure 72. Therapeutic Protein Drug Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
